The Role of Oxidative Stress in Depressive Disorders
Abstract
UNLABELLED: Studies of the World Health Organization suggest that in the year 2020, depressive disorder will be the illness with the highest burden of disease. Especially unipolar depression is the psychiatric disorder with the highest prevalence and incidence, it is cost-intensive and has a relatively high morbidity. Lately, the biological process involved in the aetiology of depression has been the focus of research. Since its emergence, the monoamine hypothesis has been adjusted and extended considerably. An increasing body of evidence points to alterations not only in brain function, but also in neuronal plasticity. The clinical presentations demonstrate these dysfunctions by accompanying cognitive symptoms such as problems with memory and concentration. Modern imaging techniques show volume reduction of the hippocampus and the frontal cortex. These findings are in line with post-mortem studies of patients with depressive disorder and they point to a significant decrease of neuronal and glial cells in cortico-limbic regions which can be seen as a consequence of alterations in neuronal plasticity in this disorder. This could be triggered by an increase of free radicals which in turn eventually leads to cell death and consequently atrophy of vulnerable neuronal and glial cell population in these regions. Therefore, research on increased oxidative stress in unipolar depressive disorder, mediated by elevated concentrations of free radicals, has been undertaken. This review gives a comprehensive overview over the current literature discussing the involvement of oxidative stress and free radicals in depression. METHODS: We have carried out a medline search "oxidative stress depression", "oxidative stress affective disorders", "free radicals and depression", "free radicals and affective disorders" "antidepressants oxidative stress" "antidepressants and free radicals". We found numerous reports elaborating depressive disorder and oxidative stress. Most of the previous studies concentrated on investigating antioxidants in human blood as well as in animal models. However, few of these reports were able to show correlations of reduced oxidative stress with antidepressant treatment and clinical outcome measures. Fewer studies elaborated the concentrations of antioxidants in the human brain and some pro-oxidative enzymes in depression. However, more studies are needed to elucidate the complex role of oxidative stress in the aetiology of depression.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Increased oxidative damage occurs quite often in depression.
“increased oxidative damage occurs quite often in depression [7–9]”
From Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches (2016) · cites this paper as [7]
Cited by
Sorted by citations
Is depression associated with increased oxidative stress? A systematic review and meta-analysis
Black, C. N., Bot, M., Scheffer, P. G., Cuijpers, P., & Penninx, B. W. J. H. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.09.025 · Cited by 711 · see citing works
ROS and Brain Diseases: The Good, the Bad, and the Ugly
Popa-Wagner, A., Mitran, S., Sivanesan, S., Chang, E., & Buga, A.-M. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/963520 · Cited by 427 · see citing works
“These include chronic diseases (Parkinson’s disease or Alzheimer’s disease) [4], acute injury of the brain (brain trauma and cerebral ischemia) [5, 6], or psychiatric disorders (autism, attention deficit hyperactivity disorder, depression, and schizophrenia) [7].”
BackgroundA systematic review of randomised control trials on the effects of yoga on stress measures and mood
Pascoe, M. C., & Bauer, I. E. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.07.013 · Cited by 366 · see citing works
García-Sánchez, A., Miranda‐Díaz, A. G., & Cardona-Muñóz, E. G. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2082145 · Cited by 333 · see citing works
Czarny, P., Wigner, P., Galecki, P., & Sliwinski, T. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.06.036 · Cited by 310 · see citing works
“and may be important participants in its pathogenesis [Michel et al. 2012].”
BackgroundDepression and Oxidative Stress: Results From a Meta-Analysis of Observational Studies
Palta, P., Samuel, L. J., Miller, E. R., & Szanton, S. L. (2014) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000009 · Cited by 277 · see citing works
Verhoeven, J. E., Révész, D., Epel, E. S., Lin, J., Wolkowitz, O. M., & Penninx, B. W. J. H. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.151 · Cited by 270 · see citing works
“The disorder has previously also been associated with dysregulations of the hypothalamus-pituitary-adrenal (HPA) axis (43,45), the immune system (46,47), the autonomic nervous system (ANS) (48,49), and increased oxidative stress (50).”
BackgroundNajjar, S., Pearlman, D. M., Devinsky, O., Najjar, A., & Zagzag, D. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-142 · Cited by 248 · see citing works
“Increased ROS synthesis ● [10,14-16,64-84] ● [64,85] ● [42,63,86]”
Jiménez‐Fernández, S., Manuel Gurpegui, A., Díaz-Atienza, F., Pérez-Costillas, L., Gerstenberg, M., & Correll, C. U. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14r09179 · Cited by 220 · see citing works
Liu, X., Zheng, P., Zhao, X., Zhang, Y., Hu, C., Li, J., Zhao, J., Zhou, J., Xie, P., & Xu, G. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00144 · Cited by 193 · see citing works
The role of oxidative and nitrosative stress in accelerated aging and major depressive disorder
Maurya, P. K., Noto, C. D. S., Rizzo, L. B., Rios, A. C., Nunes, S. O. V., Barbosa, D. S., Sethi, S., Zeni‐Graiff, M., Mansur, R. B., Maes, M. H. J., et al. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.08.016 · Cited by 170 · see citing works
Talaeı, A., Moghadam, M. H., Tabassi, S. A. S., & Mohajeri, S. A. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.11.035 · Cited by 166 · see citing works
“Some studies showed that oxidative stress was increased in depressed patients and reported the correlations between reduced oxidative stress and antidepressant treatment (Chung et al., 2013; Michel et al., 2012; Zhou et al., 2006).”
BackgroundDietary zinc and iron intake and risk of depression: a meta-analysis
Li, Z., Li, B., Song, X., & Zhang, D. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.02.006 · Cited by 156 · see citing works
The role of mitochondria in mood disorders: from physiology to pathophysiology and to treatment
Giménez-Palomo, A., Dodd, S., Anmella, G., Carvalho, A. F., Scaini, G., Quevedo, J., Pacchiarotti, I., Vieta, E., & Berk, M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.546801 · Cited by 140 · see citing works
Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation
Yang, L., Youngblood, H. A., Wu, C., & Zhang, Q. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00197-z · Cited by 143 · see citing works
Role of the intestinal microbiome, intestinal barrier and psychobiotics in depression
Trzeciak, P., & Herbet, M. (2021) · Nutrients · doi:10.3390/nu13030927 · Cited by 139 · see citing works
“However, if not inactivated, they can inhibit enzyme activity, cause lipid peroxidation, or damage DNA (deoxyribonucleic acid) and consequently lead to apoptosis or necrosis of cells [30].”
BackgroundPhysical Exercise for Treatment of Mood Disorders: A Critical Review
Hearing, C. M., Chang, W. C., Szuhany, K. L., Deckersbach, T., Nierenberg, A. A., & Sylvia, L. G. (2016) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-016-0089-y · Cited by 137 · see citing works
Efficacy of vitamin D supplementation in major depression
Vellekkatt, F., & Menon, V. (2018) · Journal of Postgraduate Medicine · doi:10.4103/jpgm.jpgm_571_17 · Cited by 149 · see citing works
Nrf2: An all-rounder in depression
Zuo, C., Cao, H., Song, Y., Gu, Z., Huang, Y., Yang, Y., Miao, J., Zhu, L., Chen, J., Jiang, Y., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102522 · Cited by 138 · see citing works
Associations between Dietary Pattern and Depression in Korean Adolescent Girls
Kim, T.-H., Choi, J.-Y., Lee, H., & Park, Y. (2015) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2015.04.005 · Cited by 137 · see citing works
Use of Carnosine for Oxidative Stress Reduction in Different Pathologies
Prokopieva, V. D., Yarygina, E. G., Bokhan, N. A., & Ivanova, S. А. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2939087 · Cited by 129 · see citing works
“It is known that OS develops in Parkinson’s and Alzheimer’s diseases [52], acute ischemic stroke [53], schizophrenia [54], depression [55], addictive disorders, alcoholism [56–58], and so forth.”
BackgroundPersimmon (Diospyros kaki) fruit: hidden phytochemicals and health claims
Butt, M. S., Sultan, M. T., Aziz, M., Naz, A., Ahmed, W., Kumar, N., & Imran, M. (2015) · EXCLI journal · doi:10.17179/excli2015-159 · Cited by 127 · see citing works
“disorders (Michel et al., 2012).”
BackgroundOrtega, M. A., Álvarez-Mon, M. Á., Montero, C. G., Fraile‐Μartinez, O., Guijarro, L. G., Lahera, G., Monserrat, J., Valls, P., Mora, F., Rodríguez–Jiménez, R., et al. (2022) · Metabolites · doi:10.3390/metabo12010050 · Cited by 125 · see citing works
Singh, A. K., Rana, H. K., Tshabalala, T., Kumar, R., Gupta, A., Ndhlala, A. R., & Pandey, A. K. (2019) · South African Journal of Botany · doi:10.1016/j.sajb.2019.06.017 · Cited by 130 · see citing works
Bhatt, S., Devadoss, T., Manjula, S. N., & Rajangam, J. (2021) · Current Neuropharmacology · doi:10.2174/1570159x18666201015155816 · Cited by 119 · see citing works
Impacts of Psychological Stress on Osteoporosis: Clinical Implications and Treatment Interactions
Kelly, R. R., McDonald, L. T., Jensen, N. R., Sidles, S. J., & LaRue, A. C. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00200 · Cited by 121 · see citing works
de Morais, H., de Souza, C. P., da Silva, L. M., Ferreira, D. M., Werner, M. F., Andreatini, R., da Cunha, J. M., & Zanoveli, J. M. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.10.011 · Cited by 111 · see citing works
Kim, H. K., Nunes, P. V., de Oliveira, K. C., Young, L. T., & Lafer, B. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.01.008 · Cited by 107 · see citing works
“Significant reduction in glial cells is also strongly implicated in MDD, which could be contributing to reduced neuronal survival and increased vulnerability to environmental stressors (Michel et al., 2012; Rajkowska, O'Dwyer, Teleki, Stockmeier, & Miguel-Hidalgo, 2007; Sibille & French, 2013).”
BackgroundInfluentialCarnosine, Small but Mighty—Prospect of Use as Functional Ingredient for Functional Food Formulation
Jukić, I., Kolobarić, N., Stupin, A., Matić, A., Kozina, N., Mihaljević, Z., Mihalj, M., Šušnjara, P., Stupin, M., Ćurić, Ž. B., et al. (2021) · Antioxidants · doi:10.3390/antiox10071037 · Cited by 112 · see citing works
Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbidities
Bernardo, I., Bozinovski, S., & Vlahos, R. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.08.005 · Cited by 108 · see citing works
“…oxidative stress is also an independent risk factor of many comorbidities such as cardio-vascular disease, osteoporosis and depressive disorders in patients without COPD (Sanchez-Rodriguez, Ruiz-Ramos, Correa-Munoz, & Mendoza-Nunez, 2007; Kawada, 2012; Michel, Pulschen, & Thome, 2012).”
BackgroundBalmus, I. M., Ciobica, A., Antioch, I., Dobrin, R., & Timofte, D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3975101 · Cited by 103 · see citing works
“group suggested that antidepressant therapy and modulation of oxidative stress are linked and are contributing in a specific way to the oxidative balance [7, 127].”
BackgroundMorris, G., Berk, M., Klein, H. C., Walder, K. R., Gałecki, P., & Maes, M. H. J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9975-2 · Cited by 99 · see citing works
Asadi, S., Gholami, M. S., Siassi, F., Qorbani, M., & Sotoudeh, G. (2019) · Phytotherapy Research · doi:10.1002/ptr.6571 · Cited by 102 · see citing works
Pandey, Y. R., Kumar, S., Gupta, B. K., Ali, J., & Baboota, S. (2016) · Nanotechnology · doi:10.1088/0957-4484/27/2/025102 · Cited by 96 · see citing works
Dima, D., Jogia, J., Collier, D. A., Vassos, E., Burdick, K. E., & Frangou, S. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.2099 · Cited by 89 · see citing works
Al-Karawi, D., Mamoori, D. A. A., & Tayyar, Y. (2015) · Phytotherapy Research · doi:10.1002/ptr.5524 · Cited by 92 · see citing works
“Several reviews confirmed that major depression is associated with decreased total antioxidant status and activation of oxidative and nitrosative pathways (Black et al., 2015; Michel et al., 2012; Palta et al., 2014).”
BackgroundLi, B., Guo, K., Zeng, L., Zeng, B., Huo, R., Luo, Y., Wang, H., Dong, M.-X., Zheng, P., Zhou, C., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-017-0078-2 · Cited by 91 · see citing works
Mohammadi, A. B., Torbati, M., Farajdokht, F., Sadigh‐Eteghad, S., Fazljou, S. M. B., Vatandoust, S. M., Golzari, S. E., & Mahmoudi, J. (2019) · Brain Research · doi:10.1016/j.brainres.2019.03.020 · Cited by 90 · see citing works
Bartoli, F., Trotta, G., Crocamo, C., Malerba, M. R., Clerici, M., & Carrà, G. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0817-7 · Cited by 79 · see citing works
NPGPx (GPx7): a novel oxidative stress sensor/transmitter with multiple roles in redox homeostasis.
Chen, Y. M., Wei, P., Hsu, J., Su, F., & Lee, W. (2016) · PubMed Central · Cited by 81 · see citing works
Epigenetics and cerebral organoids: promising directions in autism spectrum disorders
Forsberg, S. L., Ilieva, M. S., & Michel, T. M. (2018) · Translational Psychiatry · doi:10.1038/s41398-017-0062-x · Cited by 79 · see citing works
Self-citationIs depression the missing link between inflammatory mediators and cancer?
Polityńska, B., Pokorska, O., Wojtukiewicz, A. M., Sawicka, M., Mysliwiec, M., Honn, K. V., Tucker, S. C., & Wojtukiewicz, M. Z. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108293 · Cited by 80 · see citing works
Quantum effects in the brain: A review
Adams, B., & Petruccione, F. (2020) · AVS Quantum Science · doi:10.1116/1.5135170 · Cited by 80 · see citing works
Visentin, A. P. V., Colombo, R., Scotton, E., Fracasso, D. S., Rosa, A. R., Branco, C. S., & Salvador, M. M. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2972968 · Cited by 77 · see citing works
Role of Brain-Gut-Microbiota Axis in Depression: Emerging Therapeutic Avenues
Bhatt, S., Kanoujia, J., Lakshmi, S. M., Patil, C., Gupta, G., Chellappan, D. K., & Dua, K. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220329140804 · Cited by 81 · see citing works
Nguyen, H. D., Oh, H., Hoang, N. H. M., Jo, W. H., & Kim, M. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-15986-w · Cited by 74 · see citing works
“2021a; Nguyen and Kim 2021), and ROS-induced oxidative stress is related to the pathogenesis of depression (Michel et al. 2012).”
BackgroundFaria, R., Santana, M. M., Aveleira, C. A., Simões, C. S. O., Maciel, E. A., Melo, T., Santinha, D. R., Oliveira, M. M., Peixoto, F., Domingues, P. M., et al. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.04.042 · Cited by 76 · see citing works
“Up regulation of the stress hormones may induce the overproduction of free radicals and thus oxidative stress have been associated with depression progress (Michel et al., 2012).”
BackgroundAssociation of Oxidative Stress with Psychiatric Disorders
Hassan, W., Noreen, H., Gomes, V. D. C., Mohammadzai, I., da Rocha, J. B. T., & Landeira-Fernández, J. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160307145931 · Cited by 73 · see citing works
Caruso, G., Fresta, C. G., Grasso, M., Santangelo, R., Lazzarino, G., Lunte, S. M., & Caraci, F. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190712091515 · Cited by 74 · see citing works
Duong, P., Tenkorang, M. A. A., Trieu, J., McCuiston, C., Rybalchenko, N., & Cunningham, R. L. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-0283-1 · Cited by 72 · see citing works
“autism [48, 49], schizophrenia [50], Alzheimer’s disease [51], stroke [52], major depression [53, 54], and anxiety disorders [55, 56].”
BackgroundKuwano, N., Kato, T. A., Setoyama, D., Sato-Kasai, M., Shimokawa, N., Hayakawa, K., Ohgidani, M., Sagata, N., Kubo, H., Kishimoto, J., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.01.014 · Cited by 69 · see citing works
“Many studies have shown elevated oxidative stress in patients with MDD (Herken et al., 2007; Liu et al., 2015a; Maes et al., 2010), thus oxidative stress is regarded to be involved in the pathophysiology of MDD (de Melo et al., 2017; Maes et al., 2011a; Michel et al., 2012).”
Curcumin: A Golden Approach to Healthy Aging: A Systematic Review of the Evidence
Nunes, Y. C., Mendes, N. M., de Lima, E. P., Chehadi, A. C., Lamas, C. B., Haber, J., Bueno, M. D. S., Araújo, A., Catharin, V. C. S., Detregiachi, C. R. P., et al. (2024) · Nutrients · doi:10.3390/nu16162721 · Cited by 63 · see citing works
“…and inhibits the expression of monoamine oxidase enzymes [17–21]; regulates hypothalamic–pituitary–adrenal (HPA) disorders [274–276]; reduces NO [277–282]; repairs neurodegeneration and increases neurogenesis and neuronal plasticity, which normally increases BDNF levels [283–287]; regulates…”
BackgroundThe significance of routine biochemical markers in patients with major depressive disorder
Peng, Y.-F., Xiang, Y., & Wei, Y.-S. (2016) · Scientific Reports · doi:10.1038/srep34402 · Cited by 70 · see citing works
Herbet, M., Korga-Plewko, A., Gawrońska‐Grzywacz, M., Izdebska, M., Piątkowska‐Chmiel, I., Poleszak, E., Wróbel, A., Matysiak, W., Jodłowska‐Jędrych, B., & Dudka, J. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/7313090 · Cited by 67 · see citing works
“, lipids, DNA, and protein), despite adaptive activation of antioxidative defense system [11, 12].”
BackgroundResultThe Many Faces of Mitochondrial Dysfunction in Depression: From Pathology to Treatment
Caruso, G., Benatti, C., Blom, J. M. C., Caraci, F., & Tascedda, F. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00995 · Cited by 65 · see citing works
DNA Damage in Major Psychiatric Diseases
Raza, M. U., Tufan, T., Wang, Y., Hill, C. P., & Zhu, M. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9621-9 · Cited by 67 · see citing works
“The increasing evidence showed antioxidant effects of antidepressants and the relevance of intracellular oxidative pathways in the pathophysiology of major depression (Michel et al. 2007; Maes et al. 2009b, 2011, Behr et al. 2012; Michel et al. 2012).”
Parvalbumin interneuron alterations in stress-related mood disorders: A systematic review
Perlman, G., Tanti, A., & Mechawar, N. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100380 · Cited by 65 · see citing works
Li, X., Wu, T., Yu, Z., Li, T., Zhang, J., Zhang, Z., Cai, M., Zhang, W., Xiang, J. Y., & Cai, D. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.137 · Cited by 64 · see citing works
Manosso, L. M., Camargo, A., Dafré, A. L., & Rodrigues, A. L. S. (2020) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1853417 · Cited by 63 · see citing works
Psiconeuroinmunología de los trastornos mentales
Soria, V., Uribe, J., Salvat‐Pujol, N., Palao, D. J., Menchón, J. M., & Labad, J. (2017) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2017.07.006 · Cited by 63 · see citing works
“Alterations in oxidative stress have also been described.(39) There is a double interaction between this and inflammation: oxidative molecules activate inflammatory mediators, while activation of the microglia produces oxidative stress metabolites.”
BackgroundZhang, Y., Li, L., & Zhang, J. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13455 · Cited by 61 · see citing works
Lv, W.-J., Wu, X.-L., Chen, W.-Q., Li, Y.-F., Zhang, G.-F., Chao, L.-M., Zhou, J.-H., Guo, A., Liu, C., & Guo, S.-N. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7902874 · Cited by 61 · see citing works
The effects of crocin on the symptoms of depression in subjects with metabolic syndrome
Jam, I. N., Sahebkar, A. H., Eslami, S., et al. (2017) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/62891 · Cited by 61 · see citing works
Qizilbash, F. F., Ashhar, M. U., Zafar, A., Qamar, Z., Annu, Ali, J., Baboota, S., Ghoneim, M. M., Alshehri, S., & Ali, A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030656 · Cited by 61 · see citing works
Zheng, P., Chen, J.-J., Zhou, C.-J., Zeng, L., Li, K.-W., Sun, L., Liu, M.-L., Zhu, D., Liang, Z.-H., & Xie, P. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.188 · Cited by 60 · see citing works
Antidepressant and Antioxidative Effect of Ibuprofen in the Rotenone Model of Parkinson’s Disease
Zaminelli, T., Gradowski, R. W., Bassani, T. B., et al. (2014) · Neurotoxicity Research · doi:10.1007/s12640-014-9467-y · Cited by 59 · see citing works
Kingsbury, M. K., Dupuis, G., Jacka, F. N., Roy‐Gagnon, M., McMartin, S. E., & Colman, I. (2015) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2015-205858 · Cited by 58 · see citing works
Wiener, C. D., Rassier, G. T., Kaster, M. P., Jansen, K., Pinheiro, R. T., Klamt, F., Magalhães, P. V. D. S., Kapczinski, F. P., Ghisleni, G., & da Silva, R. A. (2013) · European Psychiatry · doi:10.1016/j.eurpsy.2013.05.006 · Cited by 56 · see citing works
Jordan, W., Dobrowolny, H., Bahn, S., Bernstein, H., Brigadski, T., Frodl, T., Isermann, B., Leßmann, V., Pilz, J., Rodenbeck, A., et al. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0749-7 · Cited by 58 · see citing works
“However, recent meta-analyses reported a considerable heterogeneity of results [8, 18, 38, 46].”
ResultKatrenčíková, B., Vaváková, M., Paduchová, Z., Nagyová, Z., Garaiová, I., Muchová, J., Ďuračková, Z., & Trebatická, J. (2021) · Antioxidants · doi:10.3390/antiox10081256 · Cited by 62 · see citing works
“These changes can trigger a production of reactive metabolites, resulting in cell death and the atrophy of neuronal and glial brain cells [32].”
BackgroundBüttiker, P., Weissenberger, S., Esch, T., Anders, M., Raboch, J., Ptáček, R., Kream, R. M., & Stefano, G. B. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1095923 · Cited by 64 · see citing works
“High levels of ROS have been linked to cell death and degeneration, notably in disorders that include type 2 diabetes, Alzheimer’s disease, autism, mood disorders and attention-deficit/hyperactivity disorder (ADHD), among others (Michel et al., 2012).”
BackgroundAkpınar, A., Uğuz, A. C., & Nazıroğlu, M. (2014) · The Journal of Membrane Biology · doi:10.1007/s00232-014-9652-1 · Cited by 52 · see citing works
Hou, X.-Y., Hu, Z., Zhang, D.-Z., Lu, W., Zhou, J., Wu, P.-F., Guan, X., Han, Q.-Q., Deng, S., Zhang, H., et al. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6737 · Cited by 52 · see citing works
“Redox dysregulation occurs following an increased release of reactive oxygen species and reactive nitrogen species, while the antioxidant defense is decreased (29, 37).”
InfluentialMo, F., Tang, Y., Du, P. F., Shen, Z., Yang, J., Cai, M., Zhang, Y., Li, H., & Shen, H. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.03.137 · Cited by 51 · see citing works
El-Marasy, S. A., El Awdan, S. A., Hassan, A., Ahmed-Farid, O. A., & Ogaly, H. A. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109329 · Cited by 50 · see citing works
Zhu, Y., Li, S.-L., Zhu, C., Wang, W., Zuo, W.-F., & Qiu, X. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112832 · Cited by 49 · see citing works
Badr, A. M., Attia, H., & Al-Rasheed, N. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-60026-1 · Cited by 46 · see citing works
Ferrúa, C. P., Giorgi, R., Camerini, L., do Amaral, C. C., Ghisleni, G., Pinheiro, R. T., & Nedel, F. (2019) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2019.101650 · Cited by 45 · see citing works
Yadav, M., Jindal, D. K., Dhingra, M. S., Kumar, A., Parle, M., & Dhingra, S. (2017) · Inflammopharmacology · doi:10.1007/s10787-017-0366-8 · Cited by 44 · see citing works
“Free radicals accumulate in brain tissue and stimulate neuropsychiatric disorders associated with memory loss and depression (Halliwell 2001; Maria et al. 2012; Kim et al. 2014; Choi et al. 2015; Yadav et al. 2016).”
BackgroundVariation of genes involved in oxidative and nitrosative stresses in depression
Wigner, P., Czarny, P. L., Synowiec, E., Bijak, M., Białek, K. I., Talarowska, M. E., Gałecki, P., Szemraj, J., & Śliwiński, T. (2018) · European Psychiatry · doi:10.1016/j.eurpsy.2017.10.012 · Cited by 48 · see citing works
“However, it has been proven that the overactivation of SOD may lead to the intensification of oxidative stress via H2O2 production [9].”
BackgroundInfluentialMorris, G., Walder, K. R., Berk, M., Marx, W., Walker, A. J., Maes, M. H. J., & Puri, B. K. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05590-5 · Cited by 46 · see citing works
“However, it is fair to say that the benefits seen with NAC and CoQ supplementation are relatively modest as far as SZ and BPD are concerned, and as of yet there is no evidence showing robust benefit in patients with MDD [48, 51].”
BackgroundInfluentialA dopamine metabolite stabilizes neurotoxic amyloid-β oligomers
Cataldi, R., Chia, S., Pisani, K., Ruggeri, F. S., Xu, C. K., Šneideris, T., Perni, M., Sarwat, S., Joshi, P., Kumita, J. R., et al. (2021) · Communications Biology · doi:10.1038/s42003-020-01490-3 · Cited by 42 · see citing works
Ghosh, S., Choudhury, S., Chowdhury, O., Mukherjee, S., Das, A., Sain, A., Gupta, P., Adhikary, A., & Chattopadhyay, S. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109521 · Cited by 43 · see citing works
Si̇pahi̇, H., Mat, A. F., Özhan, Y., & Aydın, A. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666221223111309 · Cited by 45 · see citing works
Lim, D. W., Park, J., Jung, J., Kim, S., Um, M. Y., Yoon, M., Kim, Y. T., Han, D., Lee, C.-H., & Lee, J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105252 · Cited by 41 · see citing works
Multiple chemical sensitivity: It's time to catch up to the science
Molot, J., Sears, M., & Anisman, H. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105227 · Cited by 40 · see citing works
Ramírez-Rodríguez, G. B., Vega‐Rivera, N. M., Oikawa‐Sala, J., Gómez‐Sánchez, A., Ortíz‐López, L., & Estrada-Camarena, E. M. (2014) · Journal of Pineal Research · doi:10.1111/jpi.12136 · Cited by 40 · see citing works
“Interestingly, free oxygen radicals are increased in depression [59,69]; therefore, the antioxidant or scavenger activity of (A) Cell survival (BrdU) g k / g m 8 2 .”
BackgroundLiu, Z., Cai, Y., & He, J. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s155144 · Cited by 40 · see citing works
“51 Another important finding of our study was that serum 8-OHdG levels were positively correlated with serum CAT levels.”
Micale, V., Bartolomeo, M. D., Martino, S. D., Štark, T., Dell’Osso, B. M., Drago, F., & D’Addario, C. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108279 · Cited by 40 · see citing works
Al-Amin, M. M., Choudhury, M. F. R., Chowdhury, A. S., Chowdhury, T. R., Jain, P., Kazi, M., Alkholief, M. A., Alshehri, S., & Reza, H. M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00384 · Cited by 40 · see citing works
Zhang, Y., Li, G., Liu, C., Guan, J., Zhang, Y., & Shi, Z. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1199510 · Cited by 38 · see citing works
Fung, A. C. H., Tse, G., Cheng, H. L., Lau, E. S. H., Luk, A. O. Y., Ozaki, R., So, T., Wong, R. Y. M., Tsoh, J., Chow, E., et al. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00261 · Cited by 38 · see citing works
Ji, Y., Luo, J., Zeng, J., Fang, Y., Liu, R., Luan, F., & Zeng, N. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.643456 · Cited by 38 · see citing works
Ludka, F. K., Dal-Cim, T. A., Binder, L. B., Constantino, L. C., Massari, C. M., & Tasca, C. I. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9882-6 · Cited by 38 · see citing works
“Considering the remarkable levels of oxygen utilization and ATP synthesis, the central nervous system (CNS) has a large susceptibility to oxidative stress [22].”
Inhibition effects of some antidepressant drugs on pentose phosphate pathway enzymes
Özaslan, M. S., Balcı, N., Demir, Y., Gürbüz, M., & Küfrevioğlu, Ö. İ. (2019) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2019.103244 · Cited by 36 · see citing works
Marques, J. G. D. S., Antunes, F. T. T., Brum, L. F. D. S., Pedron, C., de Oliveira, I. B., Ferraz, A. D. B. F., Martins, M. I. M., Dallegrave, E., & de Souza, A. H. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.113002 · Cited by 36 · see citing works
Accelerated aging in major depression: the role of nitro-oxidative stress
Luca, M., Luca, A., & Calandra, C. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/230797 · Cited by 37 · see citing works
“, prefrontal cortex) [36], loss of neuronal cells [35, 37], and reduced cerebral blood flow [38].”
BackgroundKandilarov, I., Gardjeva, P. A., Georgieva-Kotetarova, M., Zlatanova, H., Vilmosh, N., Kostadinova, I. I., Katsarova, M. N., Atliev, K. T., & Dimitrova, S. Z. (2023) · Plants · doi:10.3390/plants12173049 · Cited by 35 · see citing works
“The etiology of depression is not well understood, but oxidative stress is considered to be one of the main factors contributing to its development, along with genetic predisposition and psycho-emotional stress [65].”
BackgroundWaqar, M. A., Zaman, M., Hameed, H., Jamshaid, M., Irfan, A., Shazly, G. A., Paiva‐Santos, A. C., & Jardan, Y. A. B. (2023) · ACS Omega · doi:10.1021/acsomega.3c04444 · Cited by 34 · see citing works
Li, J., Wu, X., Yan, S., Shen, J., Tong, T., Aslam, M. S., Zeng, J., Chen, Y., Chen, W., Li, M., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04550-5 · Cited by 35 · see citing works
- Authors
- Maria Michel, T., Pulschen, D., & Thome, J.
- ORCID
- Thome, Johannes
- Venue
- Current Pharmaceutical Design
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2012-10-13
- Volume
- 18
- Issue
- 36
- Pages
- 5890-5899
- ISSN
- 1381-6128 (ISSN-L)
- OpenAlex
- W2159200793
- Cited by
- 268
- References
- 0
- Citations by year
- 2026: 11 · 2025: 10 · 2024: 17 · 2023: 16 · 2022: 32 · 2021: 21 · 2020: 40 · 2019: 25 · 2018: 19 · 2017: 18 · 2016: 22 · 2015: 16 · 2014: 10 · 2013: 11
- FWCI
- 8.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Pharmaceutical Design (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cilag
- Topics
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Biochemistry › Antioxidant Activity and Oxidative Stress
- Keywords
- oxidative stress, depression, major depressive disorder, free radicals, antioxidants, antidepressants, neuroplasticity, hippocampal atrophy, frontal cortex, monoamine hypothesis, neurodegeneration, etiology of depression
- MeSH terms
- Antidepressive Agents, Antioxidants, Brain, Depression, Humans, Risk Factors, Reactive Oxygen Species, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review